Solutions for cleaner, more reliable pharmaceutical processes 6 to 8 October 2026 | Hall 12, Booth 12M45 | Milan, Italy
Parker Hannifin, the global leader in motion and control technologies, will participate in CPHI 2026, taking place from 6 to 8 October 2026 in Milan, where the company will highlight engineered process solutions designed to support cleaner, more reliable pharmaceutical and biopharmaceutical manufacturing.
Parker will welcome visitors at Hall 12, Booth 12M45 to discuss how its technologies and technical expertise can help biopharma and pharmaceutical teams protect product quality, maintain validated operations, and navigate supply chain uncertainty, without adding unnecessary process complexity.
At the event, Parker specialists will be available to discuss solutions across biopharma and traditional pharmaceutical applications, as well as the global supply chain, including bioprocessing, filtration, single-use systems, process technologies, sensors, active pharmaceutical ingredients, drug delivery and contract manufacturing.
“Pharmaceutical manufacturers are under increasing pressure to strengthen process reliability, reduce contamination risk, and maintain compliance while keeping operations efficient,” said Jean-Philippe Minne, platform sales leader Biopharma, Parker Hannifin. “At CPHI 2026, we look forward to engaging with customers and partners on practical ways to support these priorities through engineered technologies and application expertise.”
On the booth, Parker will feature a range of technologies that support critical pharmaceutical processing needs, including PureTain® Single-Use Assemblies, the SciLog® NFF+ Automated System supporting PUPSIT requirements, SciLog® pumps and sensors, and PROPOR sterilising grade filters, including new high-area models.
Parker’s technical team will also be available to discuss key industry considerations such as PFAS-free filter options, EU GMP Annex 1 requirements, PUPSIT- Pre-Use Post Sterilisation Integrity Testing – workflows, dual sourcing strategies, contamination site reduction, and opportunities to simplify flow paths and reduce SKU complexity.
Visitors are invited to meet Parker at Hall 12, Booth 12M45 during CPHI 2026 to discuss their process, quality and sourcing requirements, and to explore how Parker can help bring their biopharma processing objectives to life.
Learn more about Parker here: CPHI 2026 | Parker
About Parker Hannifin
Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For more than a century, the company has been enabling engineering breakthroughs that lead to a better tomorrow. Learn more at www.parker.com or @parkerhannifin.
